Yan Yu-Qin, Chen Jun, Huang Yu-Qing
Department of Cardiology, People's Hospital of Shenzhen Baoan District, Shenzhen, 518100, People's Republic of China.
Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.
Diabetes Metab Syndr Obes. 2021 Jun 22;14:2851-2862. doi: 10.2147/DMSO.S313006. eCollection 2021.
The association between high-density lipoprotein cholesterol (HDL-C) and the risk of death among people with diabetes remains to be verified.
This was a nationwide, population-based cohort study in United States. A total of 6549 diabetes patients were included from the National Health and Nutrition Examination Surveys (NHANES). HDL-C concentration was divided into quintiles, and the lowest risk group (Q4: 1.32 to 1.53 mmol/L) was used as reference. Multivariate Cox proportional hazards models and restrictive cubic curves were performed to estimate hazard ratios (HRs) with 95% confidence interval (CI) for all-cause and cause-specific mortality.
During a median follow-up of 82.36 ± 50.11 months, 1546 (23.61%) cases of all-cause, 389 (5.94%) cardiovascular and 262 (4.00%) cancer mortality have occurred, respectively. After adjusting for potential covariates, a U-shaped association was found between HDL-C and all-cause mortality (minimum mortality risk at 1.37 mmol/L); the risk for all-cause mortality was significantly higher in the groups with HDL-C concentration <0.96 mmol/L (HR: 1.30; 95% CI: 1.09, 1.56; P=0.0046) and with HDL-C concentration ≥1.55 mmol/L (HR: 1.20; 95% CI: 1.00, 1.44; P=0.0481) than participants with HDL-C concentrations ranging from 1.32 to 1.53mmol/L. Nonlinear associations of HDL-C levels with both cardiovascular and cancer mortality were also observed.
A non-linear association was observed association of HDL-C with all-cause, cardiovascular and cancer mortality among diabetic patients.
高密度脂蛋白胆固醇(HDL-C)与糖尿病患者死亡风险之间的关联仍有待验证。
这是一项在美国开展的全国性、基于人群的队列研究。从国家健康与营养检查调查(NHANES)中纳入了6549名糖尿病患者。HDL-C浓度被分为五分位数,以最低风险组(Q4:1.32至1.53 mmol/L)作为参照。采用多变量Cox比例风险模型和限制性立方曲线来估计全因死亡率和特定病因死亡率的风险比(HR)及95%置信区间(CI)。
在中位随访82.36±50.11个月期间,分别发生了1546例(23.61%)全因死亡、389例(5.94%)心血管疾病死亡和262例(4.00%)癌症死亡。在对潜在协变量进行调整后,发现HDL-C与全因死亡率之间呈U形关联(HDL-C浓度为1.37 mmol/L时死亡风险最低);HDL-C浓度<0.96 mmol/L组(HR:1.30;95% CI:1.09,1.56;P = 0.0046)和HDL-C浓度≥1.55 mmol/L组(HR:1.20;95% CI:1.00,1.44;P = 0.0481)的全因死亡风险显著高于HDL-C浓度在1.32至1.53 mmol/L之间的参与者。还观察到HDL-C水平与心血管疾病和癌症死亡率之间存在非线性关联。
观察到HDL-C与糖尿病患者的全因、心血管疾病和癌症死亡率之间存在非线性关联。